KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jul 29, 2026 - 3:59PM >>  ABB India 7313  [ 0.93% ]  ACC 1370.4  [ 2.13% ]  Ambuja Cements 435  [ 2.04% ]  Asian Paints 2759.15  [ 0.82% ]  Axis Bank 1235.9  [ 1.03% ]  Bajaj Auto 11336.95  [ -0.31% ]  Bank of Baroda 243.2  [ 1.65% ]  Bharti Airtel 1950.3  [ 2.52% ]  Bharat Heavy 405.25  [ -0.09% ]  Bharat Petroleum 317.35  [ -0.83% ]  Britannia Industries 5514.8  [ 0.61% ]  Cipla 1473.45  [ 1.99% ]  Coal India 410  [ -0.02% ]  Colgate Palm 2166.05  [ 1.43% ]  Dabur India 433.45  [ 2.06% ]  DLF 670.4  [ 1.11% ]  Dr. Reddy's Lab. 1143.2  [ 0.66% ]  GAIL (India) 175.2  [ 0.06% ]  Grasim Industries 3106.7  [ -0.27% ]  HCL Technologies 1343.6  [ 1.86% ]  HDFC Bank 748.25  [ 1.74% ]  Hero MotoCorp 5135  [ -0.31% ]  Hindustan Unilever 2118.15  [ 4.70% ]  Hindalco Industries 962.25  [ 2.73% ]  ICICI Bank 1438  [ 0.71% ]  Indian Hotels Co. 738  [ 0.47% ]  IndusInd Bank 1012.45  [ 1.98% ]  Infosys 1155.5  [ 4.50% ]  ITC 286.1  [ 0.54% ]  Jindal Steel 1090.65  [ 3.45% ]  Kotak Mahindra Bank 390.3  [ 1.27% ]  L&T 3930.35  [ 2.55% ]  Lupin 2446  [ 2.14% ]  Mahi. & Mahi 3223.15  [ -1.51% ]  Maruti Suzuki India 13939  [ 0.98% ]  MTNL 27.29  [ 1.98% ]  Nestle India 1498  [ 0.22% ]  NIIT 97.7  [ 2.41% ]  NMDC 85.88  [ 2.32% ]  NTPC 343.5  [ -0.09% ]  ONGC 238.25  [ -0.23% ]  Punj. NationlBak 111  [ -0.58% ]  Power Grid Corpn. 282.75  [ -0.89% ]  Reliance Industries 1276  [ 0.64% ]  SBI 1013.8  [ 0.10% ]  Vedanta 264.5  [ 1.97% ]  Shipping Corpn. 278.8  [ 0.00% ]  Sun Pharmaceutical 1989.75  [ 0.63% ]  Tata Chemicals 678.4  [ 0.49% ]  Tata Consumer 1096.9  [ 1.35% ]  Tata Motors Passenge 329.85  [ 1.76% ]  Tata Steel 187.3  [ 2.52% ]  Tata Power Co. 377  [ 1.55% ]  Tata Consult. Serv. 2445.6  [ 1.99% ]  Tech Mahindra 1644.35  [ 0.56% ]  UltraTech Cement 11998  [ 0.24% ]  United Spirits 1503.6  [ -0.36% ]  Wipro 183.55  [ 1.35% ]  Zee Entertainment 108.1  [ 0.42% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

MEDICAMEN BIOTECH LTD.

29 July 2026 | 03:59

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE646B01010 BSE Code / NSE Code 531146 / MEDICAMEQ Book Value (Rs.) 203.14 Face Value 10.00
Bookclosure 19/09/2025 52Week High 448 EPS 7.11 P/E 33.52
Market Cap. 323.11 Cr. 52Week Low 212 P/BV / Div Yield (%) 1.17 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
MBL was incorporated as a public limited company under the Companies Act, 1956, on December 22, 1993. The certificate of commencement of business was obtained on January 31, 1994. The company has jointly been promoted by Mr.V.Kumar, Mr.Bal Kishan Gupta, Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh. MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst, Cadila, Hindustan Ciba, Purepharma, Oboi Labs etc. and exporting to countries like Germany, Russia, Holland, CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales. MBL has obtained permission for production of tablets, capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited, New Delhi and Pure Pharma Private Limited, Indore respectively. 2010 -The Company has recommended a final dividend of Rs. 0.75 per equity share (being 7.5% on the face value of Rs. 10 per share) -The Company appointed Mr. B.K.Gupta as Managing Director. 2011 -The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan. 2013 -Ms. Harshita Sharma has been appointed as Additional Director of the company. 2016 -Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd. 2019 -FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant. 2020 -Global API Facility started Dahej API Plant. 2021 -Operations started Haridwar formulation Unit II(FDF). 2023 -Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.

2024
-Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece.
-Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.